Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Home Search
influenza - search results
If you're not happy with the results, please do another search
Flu jab will be freely available to more than 35 million people this winter
Health and Social Care Secretary Sajid Javid has announced that over 35 million people will have access to a free flu vaccine this winter.
Supporting vaccination campaigns through high-quality cold storage solutions
Arthur Goudena, Marketing Manager of PHC Europe, explains how the company’s cold storage solutions are available to support COVID-19 vaccination campaigns across Europe.
Bioinformatics focus: Can we break the glycocode?
Frederique Lisacek from SIB Swiss Institute of Bioinformatics, provides the computer-based tools for exploring ways of breaking the glycocode.
SWINOSTICS: Field-diagnostics in pig farming
Here, R&D Director Alessandro Giusti details the work of the Horizon 2020 funded SWINOSTICS project to tackle viruses causing epidemics in pig farming.
Communication strategies are critical for vaccine rollout
Adam Enterkin, Global SVP Sales at BlackBerry, explores the critical role of secure crisis communications for the vaccine rollout and the value of a communication strategy to combat misinformation.
Immune system research: Vaccines and immunotherapeutics
Dr Babita Agrawal, Professor at the University of Alberta, discusses both the vital present and future roles of vaccines and immunotherapeutics in combatting COVID-19.
Study finds 30.8% of hospitalised COVID patients are obese
An international study examined hospitalised COVID patients across 11 countries - finding that obese patients are 73% more likely to need invasive respiratory support.
A long-term collaborative approach to addressing health inequality
Christine Hancock, Founder and Director at C3 Collaborating for Health, discusses the ongoing issue of health inequality that COVID-19 has exposed, and how to ensure healthy lives for all.
What do we know about obesity and COVID-19?
Dr Deborah Lee, Dr Fox Online Pharmacy, highlights the possible reasons why being obese affects the risk of COVID-19 infection.
Plague: The first pandemic disease
Ann G. Matthysse, Professor of Biology from The University of North Carolina at Chapel Hill, writes in detail about plague, the first pandemic disease including comment on bacteria.
Sterilair PRO – Biological air treatment
Used in medical settings for over 20 years, Sterilair is now being used in a wide range of close-contact environments to maintain healthy air quality.
Commission launches “HERA Incubator” project to fight COVID mutations
The European Commission today (17 February) launched the "HERA Incubator", as both a "blueprint" for long-term health emergencies and a way to stop COVID-19 mutations.
UK Government and CureVac partnership to tackle COVID-19 virus variants
The UK Government and vaccine manufacturer CureVac have partnered to rapidly develop new vaccines in response to new COVID-19 virus variants.
Third of Americans say they are unlikely to get COVID-19 vaccine
A new study by the University of California, Davis has found that a third of Americans are either unlikely or hesitant to get a COVID-19 vaccine when it becomes available.
COVID-19 mortality rates 13 times higher in pregnant women
According to a new study examining the effects of coronavirus in pregnant women, COVID-19 mortality rates showed to be 13 times higher in pregnant mothers.
Flu vaccine sees highest uptake on record
Over 80% of those aged 65+ in England have received the flu vaccine so far this year – the highest uptake on record.
Coordinating research on pandemic preparedness and rapid response
Dr Charu Kaushic, Chair of GloPID-R, and Dr Geneviève Boily-Larouche, CIHR Institute of Infection and Immunity, provide a perspective on pandemic preparedness and response, including lessons learned for global coordination among research funders.
Removal of inflammatory ‘evil humors’ – the key to treating COVID-19 complications?
Phillip P. Chan, MD, PhD, Chief Executive Officer of CytoSorbents Corporation (NASDAQ: CTSO), discusses the use of CytoSorb, a broad-spectrum blood purification technology to treat cytokine storm and hyperinflammation in critically ill COVID-19 patients.
Dr Sylvie C. Briand – World Health Organization (WHO)
Dr Briand is the director of the Global Infectious Hazard Preparedness department (GIH) at the World Health Organization (WHO)
There, she is in charge of advancing global efforts to prevent and control existing and emerging infectious diseases such as COVID-19 but also other dangerous pathogens like pandemic influenza, plague, Nipah...
Andrea Ammon – European Centre for Disease Prevention and Control
Dr Andrea Ammon, MD, MPH, was appointed Director of ECDC in June 2017.
